Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.

British journal of cancer - 12 Jan 2004

Jézéquel P, Campion L, Joalland M-P, Millour M, Dravet F, Classe J-M, Delecroix V, Deporte R, Fumoleau P, Ricolleau G

Abstract excerpt

This study screened large cohorts of node-positive and node-negative breast cancer patients to determine whether the G388R mutation of the FGFR4 gene is a useful prognostic marker for breast cancer as reported by Bange et al in 2002. Node-positive (n=139) and node-negative (n=95) breast cancer co...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibroblast Growth Factors

Share to Mutation, Missense

Share to Polymorphism, Restriction Fragment Length

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Receptors, Fibroblast Growth Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 14710228
DOI: 10.1038/sj.bjc.6601450
PMCID: PMC2395301

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-14710228-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.PMID 14710228Read ↗

FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.Semantic proximity Read ↗

Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.Semantic proximity Read ↗

FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.Semantic proximity Read ↗

The fibroblast growth factor receptor gene Arg388 allele is not associated with early lymph node metastasis of breast cancer.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.Semantic proximity Read ↗

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.Semantic proximity Read ↗

FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.Semantic proximity Read ↗

Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?Semantic proximity Read ↗

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.Semantic proximity Read ↗

A single nucleotide change in the mouse genome accelerates breast cancer progression.Semantic proximity Read ↗

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.